AssetMark Inc’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-1,581
| Closed | -$5K | – | 1500 |
|
|
2019
Q2 | $5K | Buy |
1,581
+421
| +36% | +$1.33K | ﹤0.01% | 1070 |
|
|
2019
Q1 | $4K | Buy |
1,160
+157
| +16% | +$541 | ﹤0.01% | 1104 |
|
|
2018
Q4 | $3K | Sell |
1,003
-728
| -42% | -$2.18K | ﹤0.01% | 1194 |
|
|
2018
Q3 | $5K | Sell |
1,731
-148
| -8% | -$427 | ﹤0.01% | 1188 |
|
|
2018
Q2 | $4K | Sell |
1,879
-59
| -3% | -$126 | ﹤0.01% | 1217 |
|
|
2018
Q1 | $6K | Buy |
1,938
+110
| +6% | +$341 | ﹤0.01% | 1143 |
|
|
2017
Q4 | $5K | Buy |
1,828
+1,683
| +1,161% | +$4.6K | ﹤0.01% | 1268 |
|
|
2017
Q3 | $0 | Buy |
145
+141
| +3,525% | – | ﹤0.01% | 1705 |
|
|
2017
Q2 | $0 | Buy |
+4
| New | – | ﹤0.01% | 1561 |
|
|
2017
Q1 | – | Sell |
-49
| Closed | – | – | 1544 |
|
|
2016
Q4 | $0 | Buy |
+49
| New | – | ﹤0.01% | 1466 |
|